RSNA 2015

Breast MRI after mammography may identify additional aggressive cancers

Additional breast cancers found with MRI are sometimes larger and potentially more aggressive than those found on mammography, according to a study published online in the journal Radiology.

Mammography and MR imaging in a 46-year-old woman with a palpable mass in the...
Mammography and MR imaging in a 46-year-old woman with a palpable mass in the right breast. A: Mediolateral oblique (left) and spot compression (right) mammograms in the right breast show a mass in the upper-outer quadrant. B: Sagittal dynamic breast MR images in the right breast show an en-hancing mass with speculated, or spiky, margins in the right upper outer quadrant, an additional focus near the nipple (DCIS), and nonmass enhancement in the inferior quadrants (DCIS). The additional lesions were not visible at US and were biopsied with MR imaging guidance.
Source: Radiological Society of North America

Researchers said that in some cases MRI findings of additional cancers not seen on mammography may necessitate a change in treatment.

Breast MRI is the most sensitive technique for the detection of breast cancer, with widespread application in the screening of high-risk patients and pre-surgical planning. In younger women and women with dense breasts, MRI is effective in the detection of what are known as multicentric cancers, meaning breast cancers involving two or more distinct primary tumors, usually in different quadrants of the breast. However, there has been some debate about the clinical significance of multicentric cancers found with MRI.

"Patients with clinically insignificant cancers undergoing potential overtreatment versus patients who may be undertreated is at the heart of the controversy surrounding breast MRI," said the study's lead author Chiara Iacconi, M.D., from the Breast Unit at USL1 Massa-Carrara in Carrara, Italy.

To learn more, Dr. Iacconi and colleagues reviewed records from 2,021 patients with newly diagnosed breast cancer who underwent biopsy after preoperative MRI. Of the 2,021 patients, 285, or 14 percent, had additional cancer detected on MRI that was hidden from view on mammography.

In 73 of those 285 patients, or 25.6 percent, MRI identified at least one additional cancer in a different quadrant of the breast than the index cancer, or the cancer detected by mammography and/or breast palpation.

These multicentric cancers were larger than the known index cancer in 17 of the 73 patients, or 23.3 percent. In addition, the MRI-detected multicentric cancers were greater than 1 centimeter in size in 25 percent of the 73 patients.

"We believe invasive cancer larger than 1 centimeter is clinically relevant disease," Dr. Iacconi said. "In general, it is accepted that radiation can likely treat invasive cancer less than 1 centimeter, but lesions larger than 1 centimeter, especially invasive carcinomas, may not be reliably treated with conservation."

The additional MRI-detected multicentric cancers were found mostly in patients with heterogeneously dense or extremely dense breasts. However, MRI also detected additional disease in 19 percent of patients with fatty or scattered fibroglandular tissue.

"The results show that multicentric cancer detected on breast MRI after mammography appears to represent a larger tumor burden in approximately a quarter of patients and can result in potential changes to cancer grade and treatment," Dr. Iacconi said.

Source: Radiological Society of North America

30.11.2015

Read all latest stories

Related articles

High-grade DCIS detection rates increase in older women

The mammography detection rate of an early-stage but potentially invasive type of breast cancer rises with age, according to a large new study from Germany published online in the journal Radiology.

Screening

AB-MRI could be the ideal screening tool

MRI is increasingly relevant to cancer management, especially to detect breast carcinoma. Professor Christiane K Kuhl from the department of diagnostic and interventional radiology at the University…

ECR 2015

Carestream Improves Digital Breast Tomosynthesis

Carestream will show enhancements to its digital breast tomosynthesis (DBT) module including a slabbing tool, improved workflow capabilities and the display of DICOM-compliant 2D synthetic views…

Related products

LIS, Middleware, POCT

Beckman Coulter - REMISOL Advance

Beckman Coulter, Inc.

Displays - Mammo

Barco - Nio 5MP

Barco N.V.

Film-screen mammography

Canon - Harmonia

Canon Europa NV

Digital mammography

DMS Imaging - Serenys DR Bym

DMS

Research use only (RUO)

Eppendorf - Mastercycler nexus X2

Eppendorf AG

Accessories / Complementary systems

GCTechnology - CIRS Phantoms

GCTechnology GmbH